Skip to main content
Clinical Trials/ISRCTN93220632
ISRCTN93220632
Completed
未知

The efficacy of transcranial direct current stimulation (tDCS) in the treatment of depression and brain functional changes compared to venlafaxine: A four week, double-blind, parallel, randomized study with an eight week, open-label, follow-up study

Ministry of Health, Czech Republic0 sites57 target enrollmentOctober 2, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Depression
Sponsor
Ministry of Health, Czech Republic
Enrollment
57
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31695391 results (added 02/04/2020)

Registry
who.int
Start Date
October 2, 2015
End Date
April 24, 2019
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ministry of Health, Czech Republic

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients suffering from major depressive disorder (recurrent or single episode) diagnosed according to Diagnostic and Statistical Manual of the American Psychiatric Association\-IV. revision criteria, confirmed using The Mini\-International Neuropsychiatric Interview \- M.I.N.I., Czech version 5\.0\.0
  • 2\. Patients fulfilling at least Stage I criteria for resistant depression according to Thase and Rush (\=1 previous, unsuccessful, adequate, antidepressant treatment)
  • 3\. The mental ability to understand and sign Informed Consent Form
  • 4\. The score in the Montgomery and Åsberg Rating Scale (MADRS) \=25 and the score in Clinical Global Impression \=4
  • 5\. Inpatients in the double\-blind phase of treatment
  • 6\. Age between 18 and 65 years
  • 7\. Right handedness

Exclusion Criteria

  • 1\. Psychiatric comorbidity on axis I and II according to DSM IV in the 6 months before enrollment to the study
  • 2\. Psychotic, bipolar disorder or dementia in the history
  • 3\. Contraindications of venlafaxine treatment according to SPC
  • 4\. Contraindications of MRI (metallic plates in the head, applied pacemaker or other electronic
  • stimulation devices, etc.)
  • 5\. Contraindications of tDCS (skin disease, superficial injury and fracture or infraction of skull in the stimulation area, epilepsy, metallic plates in the head)
  • 6\. Pregnancy or breast\-feeding
  • 7\. Patients with severe somatic disorders (cardiovascular disease, neoplasms, endocrinology
  • disorders etc.) that could be associated with depression due to somatic diseases
  • 8\. Patients treated with electroconvulsive therapy less than 3 months before enrollment or suffering

Outcomes

Primary Outcomes

Not specified

Similar Trials